Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-09

Clinical Trial Update: A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study results for tiragolumab in combination with atezolizumab in chemotherapy-naïve patients with locally advanced or metastatic non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Tiragolumab (tiragolumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-07-09